Mutual of America Capital Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-6,247
Closed -$362K 1465
2024
Q3
$362K Sell
6,247
-710
-10% -$34.9K ﹤0.01% 1242
2024
Q2
$282K Sell
6,957
-297
-4% -$11.8K ﹤0.01% 1309
2024
Q1
$305K Sell
7,254
-18
-0.2% -$702 ﹤0.01% 1300
2023
Q4
$279K Sell
7,272
-101
-1% -$3.36K ﹤0.01% 1326
2023
Q3
$227K Sell
7,373
-496
-6% -$17.1K ﹤0.01% 1343
2023
Q2
$249K Sell
7,869
-230
-3% -$7.89K ﹤0.01% 1351
2023
Q1
$295K Sell
8,099
-222
-3% -$7.77K ﹤0.01% 1287
2022
Q4
$246K Buy
8,321
+516
+7% +$16.6K ﹤0.01% 1334
2022
Q3
$304K Buy
7,805
+1,404
+22% +$64.3K ﹤0.01% 1231
2022
Q2
$247K Buy
6,401
+959
+18% +$36.5K ﹤0.01% 1262
2022
Q1
$264K Buy
5,442
+282
+5% +$14.5K ﹤0.01% 1267
2021
Q4
$379K Buy
5,160
+143
+3% +$11.7K ﹤0.01% 1177
2021
Q3
$457K Buy
5,017
+3,141
+167% +$267K ﹤0.01% 1134
2021
Q2
$118K Buy
+1,876
New +$69.4K ﹤0.01% 1531

Other funds holding ASTH

Mutual of America Capital Management's ASTH Position: Q4 2024 in Review

Mutual of America Capital Management sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 6,247 shares — an estimated $362K sold.

Mutual of America Capital Management first reported a position in ASTH in Q2 2021 and held it in 14 quarters. The position peaked at $457K in Q3 2021. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Mutual of America Capital Management reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Mutual of America Capital Management sold 6,247 Astrana Health shares in Q4 2024, an estimated $362K.
  • Mutual of America Capital Management first reported a position in Astrana Health in Q2 2021 and held it in 14 quarters.
  • Mutual of America Capital Management's Astrana Health position peaked at $457K in Q3 2021.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Mutual of America Capital Management's 13F filing for Q4 2024, filed 5 Feb 2025.